drugset / Trial / NCT02914054

Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone

NCT02914054

RandomizedParallel-groupQuadruple-blindTreatment

Summary

In this prospective, randomized, controlled clinical trial investigators' aim was to compare the efficacy and the adverse effect of 3 therapy cycles of HD-DXM versus conventional treatment with PDN for untreated adult patients with ITP. In this study standardized criteria and definitions were used according to consensus international working group guideline for ITPto compare clinical outcomes of the two corticosteroid treatment regimens and determine the superior regimen as a first line strategy for new primary ITP in adults

Timeline

Start
2016-10-01
Primary completion
2017-09-15
Completion
2017-09-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 40 mg Intravenous
Comparator Prednisone Other / unclassified 1 mg/kg Oral